Chr. Hansen: shares dip after UBS downgrade.
(CercleFinance.com) - Shares in Danish food ingredient maker Chr.
Hansen have shed 0.3% at 538.5 Danish kronor on Monday morning, after UBS downgraded its rating on the stock from "buy" to "neutral".
UBS analysts, which have cut their target price for the share to 530 Danish kronor, justified their decision by the stock's 12% rally since June and a "significant increase in positive investor sentiment."
"To be more positive we would predominantly need more confidence in bioprotection in emerging markets," they wrote in a research report.
Chr. Hansen is a bioscience company that makes products such as enzymes, probiotics and natural colours.
The stock has risen by 39.5% in 2017.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
Hansen have shed 0.3% at 538.5 Danish kronor on Monday morning, after UBS downgraded its rating on the stock from "buy" to "neutral".
UBS analysts, which have cut their target price for the share to 530 Danish kronor, justified their decision by the stock's 12% rally since June and a "significant increase in positive investor sentiment."
"To be more positive we would predominantly need more confidence in bioprotection in emerging markets," they wrote in a research report.
Chr. Hansen is a bioscience company that makes products such as enzymes, probiotics and natural colours.
The stock has risen by 39.5% in 2017.
Copyright (c) 2017 CercleFinance.com. All rights reserved.